These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8077091)

  • 1. The use of contrast-enhanced magnetic resonance imaging to define ischemic injury after reperfusion. Comparison in normal and hypertrophied hearts.
    Lauerma K; Saeed M; Wendland MF; Derugin N; Yu KK; Higgins CB
    Invest Radiol; 1994 May; 29(5):527-35. PubMed ID: 8077091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verapamil reduces the size of reperfused ischemically injured myocardium in hypertrophied rat hearts as assessed by magnetic resonance imaging.
    Lauerma K; Saeed M; Wendland MF; Derugin N; Yu KK; Higgins CB
    Am Heart J; 1996 Jan; 131(1):14-23. PubMed ID: 8554001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AUR Memorial Award. Identification of myocardial cell death in reperfused myocardial injury using dual mechanisms of contrast-enhanced magnetic resonance imaging.
    Geschwind JF; Wendland MF; Saeed M; Lauerma K; Derugin N; Higgins CB
    Acad Radiol; 1994 Dec; 1(4):319-25. PubMed ID: 9419506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of myocardial salvage after ischemia and reperfusion using magnetic resonance imaging and spectroscopy.
    Wolfe CL; Moseley ME; Wikstrom MG; Sievers RE; Wendland MF; Dupon JW; Finkbeiner WE; Lipton MJ; Parmley WW; Brasch RC
    Circulation; 1989 Oct; 80(4):969-82. PubMed ID: 2791255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of area at risk during coronary occlusion and reperfusion by means of MR perfusion imaging.
    Szolar DH; Saeed M; Wendland M; Sakuma H; Stiskal MA; Derugin N; Higgins CB
    Acta Radiol; 1997 Jul; 38(4 Pt 1):479-88. PubMed ID: 9240664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of potassium-channel opener therapy on reperfused infarction in hypertrophied hearts: demonstration of preconditioning by using functional and contrast-enhanced magnetic resonance imaging.
    Schalla S; Higgins CB; Chujo M; Saeed M
    J Cardiovasc Pharmacol Ther; 2004 Sep; 9(3):193-202. PubMed ID: 15378140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accentuation of high susceptibility of hypertrophied myocardium to ischemia: complementary assessment of Gadophrin-enhancement and left ventricular function with MRI.
    Schalla S; Wendland MF; Higgins CB; Ebert W; Saeed M
    Magn Reson Med; 2004 Mar; 51(3):552-8. PubMed ID: 15004797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of T1-enhancing and magnetic susceptibility magnetic resonance contrast agents for demarcation of the jeopardy area in experimental myocardial infarction.
    Yu KK; Saeed M; Wendland MF; Dae MW; Velasquez-Rocha S; Derugin N; Higgins CB
    Invest Radiol; 1993 Nov; 28(11):1015-23. PubMed ID: 7506243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media.
    Saeed M; Lund G; Wendland MF; Bremerich J; Weinmann H; Higgins CB
    Circulation; 2001 Feb; 103(6):871-6. PubMed ID: 11171797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of t2-weighted magnetic resonance imaging early after myocardial infarction in dogs: comparison with bis-gadolinium-mesoporphyrin enhanced T1-weighted magnetic resonance imaging and functional data from cine magnetic resonance imaging.
    Dymarkowski S; Ni Y; Miao Y; Bogaert J; Rademakers F; Bosmans H; Marchal G
    Invest Radiol; 2002 Feb; 37(2):77-85. PubMed ID: 11799331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reperfused myocardial infarctions on T1- and susceptibility-enhanced MRI: evidence for loss of compartmentalization of contrast media.
    Saeed M; Wendland MF; Masui T; Higgins CB
    Magn Reson Med; 1994 Jan; 31(1):31-9. PubMed ID: 8121266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multislice computed tomography and magnetic resonance imaging for the assessment of reperfused acute myocardial infarction.
    Baks T; Cademartiri F; Moelker AD; Weustink AC; van Geuns RJ; Mollet NR; Krestin GP; Duncker DJ; de Feyter PJ
    J Am Coll Cardiol; 2006 Jul; 48(1):144-52. PubMed ID: 16814660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of reperfused myocardial infarction by Gd-DOTA-enhanced magnetic resonance imaging. An experimental study.
    Ovize M; Revel D; de Lorgeril M; Pichard JB; Dandis G; Delaye J; Renaud S; Amiel M
    Invest Radiol; 1991 Dec; 26(12):1065-70. PubMed ID: 1765439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depiction of reperfused myocardial infarction using contrast-enhanced spin echo and gradient echo magnetic resonance imaging.
    Geschwind JF; Saeed M; Wendland MF; Higgins CB
    Invest Radiol; 1998 Jul; 33(7):386-92. PubMed ID: 9659590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of myocardial reperfusion with echo planar magnetic resonance imaging. Discrimination between occlusive and reperfused infarctions.
    Saeed M; Wendland MF; Yu KK; Lauerma K; Li HT; Derugin N; Cavagna FM; Higgins CB
    Circulation; 1994 Sep; 90(3):1492-501. PubMed ID: 7522135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occlusive and reperfused myocardial infarction: detection by using MR imaging with gadolinium polylysine enhancement.
    Lim TH; Lee DH; Kim YH; Park SW; Park PH; Seo DM; Kim ST; Lee TK; Mun CW
    Radiology; 1993 Dec; 189(3):765-8. PubMed ID: 7694313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts.
    Judd RM; Lugo-Olivieri CH; Arai M; Kondo T; Croisille P; Lima JA; Mohan V; Becker LC; Zerhouni EA
    Circulation; 1995 Oct; 92(7):1902-10. PubMed ID: 7671375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of severity of myocardial injury on distribution of macromolecules: extravascular versus intravascular gadolinium-based magnetic resonance contrast agents.
    Schwitter J; Saeed M; Wendland MF; Derugin N; Canet E; Brasch RC; Higgins CB
    J Am Coll Cardiol; 1997 Oct; 30(4):1086-94. PubMed ID: 9316544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating coronary reperfusion during acute myocardial infarction in a canine model by gadolinium-DTPA-enhanced magnetic resonance imaging.
    Tanabe K; Ishibashi Y; Shimada T; Tsukihashi H; Hatano J; Oyake N; Morioka S; Moriyama K; Sugimura K; Yuasa K
    Jpn Circ J; 1993 May; 57(5):458-66. PubMed ID: 7685430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol Confers Protection Against Ischemia/Reperfusion Injury by Increase of Angiotensin (1-7) Expression in a Rat Model of Myocardial Hypertrophy.
    Soltan F; Esmaili Dahej M; Yadegari M; Moradi A; Hafizi Barjin Z; Safari F
    J Cardiovasc Pharmacol; 2021 Jul; 78(1):e55-e64. PubMed ID: 34232225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.